CPS is calculated based on the number of PD-L1-positive cancer and mononuclear inflammatory cells in relation to total viable tumor cells, while TPS considers the number of PD-L1-positive neoplastic cells in relation to the total number of viable tumor cells [32]. The gene discussed is CD274; the disease is cancer.